Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Stevens

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|June 6, 2022
Redefine the Role of Spot-Scanning Proton Beam Therapy for the Single Brain Metastasis Stereotactic RadiosurgerySheng Chang, Gang Liu, Lewei Zhao, et al.
Journal of Applied Clinical Medical Physics|April 16, 2026
Commissioning and clinical implementation of Monaco treatment planning system on a compact pencil beam scanning proton therapy systemXiangkun Xu, Xiaoda Cong, Jian Liang, et al.
Advances in Radiation Oncology|October 14, 2021
Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 TrialJacob S Parzen, Michael D Chuong, John Chang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2011
Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancerGerold Bepler, Thomas J Dilling, Henry Wagner, et al.
Gastroenterology|June 25, 2011
TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's diseaseElaine R Nimmo, Craig Stevens, Anne M Phillips, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2007
Potent oxindole based human beta3 adrenergic receptor agonistsF Craig Stevens, William E Bloomquist, Anthony G Borel, et al.
Biomolecules|April 20, 2019
Regulation of the Expression of DAPK1 by SUMO PathwayQingshui Wang, Xiuli Zhang, Ling Chen, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 26, 2024
Investigate potential clinical benefits and linear energy transfer sparing utilizing proton arc therapy for hepatocellular carcinomaPeilin Liu, Xi Cao, Raymond Dalfsen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resectionNoah A Taylor, Zhongxing X Liao, James D Cox, et al.
Thrombosis Research|October 28, 2022
Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE)Parker Knueppel, Seo Hyoun Bang, Camille Troyer, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|June 6, 2022
Redefine the Role of Spot-Scanning Proton Beam Therapy for the Single Brain Metastasis Stereotactic RadiosurgerySheng Chang, Gang Liu, Lewei Zhao, et al.
Journal of Applied Clinical Medical Physics|April 16, 2026
Commissioning and clinical implementation of Monaco treatment planning system on a compact pencil beam scanning proton therapy systemXiangkun Xu, Xiaoda Cong, Jian Liang, et al.
Advances in Radiation Oncology|October 14, 2021
Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 TrialJacob S Parzen, Michael D Chuong, John Chang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2011
Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancerGerold Bepler, Thomas J Dilling, Henry Wagner, et al.
Gastroenterology|June 25, 2011
TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's diseaseElaine R Nimmo, Craig Stevens, Anne M Phillips, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2007
Potent oxindole based human beta3 adrenergic receptor agonistsF Craig Stevens, William E Bloomquist, Anthony G Borel, et al.
Biomolecules|April 20, 2019
Regulation of the Expression of DAPK1 by SUMO PathwayQingshui Wang, Xiuli Zhang, Ling Chen, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 26, 2024
Investigate potential clinical benefits and linear energy transfer sparing utilizing proton arc therapy for hepatocellular carcinomaPeilin Liu, Xi Cao, Raymond Dalfsen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resectionNoah A Taylor, Zhongxing X Liao, James D Cox, et al.
Thrombosis Research|October 28, 2022
Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE)Parker Knueppel, Seo Hyoun Bang, Camille Troyer, et al.
Pageof 13